Visualization of Active Glucocerebrosidase in Rodent Brain with High Spatial Resolution following In Situ Labeling with Fluorescent Activity Based Probes

Daniela Herrera Moro Chao, Wouter W. Kallemeijn, Andre R. A. Marques, Marie Orre, Roelof Ottenhoff, Cindy van Roomen, Ewout Foppen, Maria C. Renner, Martina Moeton, Marco van Eijk, Rolf G. Boot, Willem Kamphuis, Elly M. Hol, Jan Aten, Hermen S. Overkleeft, Andries Kalsbeek, Johannes M. F. G. Aerts*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review


Gaucher disease is characterized by lysosomal accumulation of glucosylceramide due to deficient activity of lysosomal glucocerebrosidase (GBA). In cells, glucosylceramide is also degraded outside lysosomes by the enzyme glucosylceramidase 2 (GBA2) of which inherited deficiency is associated with ataxias. The interest in GBA and glucosylceramide metabolism in the brain has grown following the notion that mutations in the GBA gene impose a risk factor for motor disorders such as alpha-synucleinopathies. We earlier developed a beta-glucopyranosylconfigured cyclophellitol-epoxide type activity based probe (ABP) allowing in vivo and in vitro visualization of activemolecules of GBA with high spatial resolution. Labeling occurs through covalent linkage of the ABP to the catalytic nucleophile residue in the enzyme pocket. Here, we describe a method to visualize active GBA molecules in rat brain slices using in vivo labeling. Brain areas related to motor control, like the basal ganglia and motor related structures in the brainstem, show a high content of active GBA. We also developed a beta-glucopyranosyl cyclophellitol-aziridine ABP allowing in situ labeling of GBA2. Labeled GBA2 in brain areas can be identified and quantified upon gel electrophoresis. The distribution of active GBA2 markedly differs from that of GBA, being highest in the cerebellar cortex. The histological findings with ABP labeling were confirmed by biochemical analysis of isolated brain areas. In conclusion, ABPs offer sensitive tools to visualize active GBA and to study the distribution of GBA2 in the brain and thus may find application to establish the role of these enzymes in neurodegenerative disease conditions such as alpha-synucleinopathies and cerebellar ataxia.

Original languageEnglish
Article number0138107
Number of pages20
JournalPLoS ONE [E]
Issue number9
Publication statusPublished - 29 Sept 2015




Dive into the research topics of 'Visualization of Active Glucocerebrosidase in Rodent Brain with High Spatial Resolution following In Situ Labeling with Fluorescent Activity Based Probes'. Together they form a unique fingerprint.

Cite this